Mid Cap
Medical Instruments & Supplies
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
1
Avantor
AVTR
$9.75B
| $9.75B | $14.42 | 1.12% |
|
2
AptarGroup
ATR
$8.57B
| $8.57B | $134.72 | 0.02% |
|
3
Stevanato
STVN
$6.2B
| $6.2B | $22.70 | 1.93% |
|
4
Bausch + Lomb
BLCO
$6.16B
| $6.16B | $17.25 | 0.4% |
|
5
Teleflex
TFX
$5.94B
| $5.94B | $140.18 | 1.35% |
|
6
Merit Medical Systems
MMSI
$5.44B
| $5.44B | $91.09 | 0.9% |
|
|
MMED
7
MiniMed Group Inc
MMED
$5.32B
| $5.32B | $18.92 | 5.12% |
|
8
ICU Medical
ICUI
$4.56B
| $4.56B | $182.24 | 0.17% |
|
9
Envista
NVST
$4.41B
| $4.41B | $27.47 | 0.48% |
|
10
Pulse Biosciences
PLSE
$3.49B
| $3.49B | $49 | 0.26% |
|
11
Warby Parker
WRBY
$3.21B
| $3.21B | $26 | 0.8% |
|
12
AtriCure
ATRC
$2.48B
| $2.48B | $48.68 | 1.22% |
|
13
Dentsply Sirona
XRAY
$2.19B
| $2.19B | $10.97 | 0.73% |
|
Mid Cap Medical Instruments & Supplies Stocks at a Glance
Medical instruments and supplies companies make the consumables and tools of daily care — syringes, catheters, surgical instruments, dental equipment, and eyewear. Recurring, procedure-driven demand makes the group defensive, with razor-and-blade consumable models supporting stable margins.
There are 13 mid cap Medical Instruments & Supplies stocks — companies in the Medical Instruments & Supplies industry with a market cap between $2B and $10B — worth a combined $67.7B.
The largest by market cap are Avantor (AVTR) at $9.75B, AptarGroup (ATR) at $8.57B and Stevanato (STVN) at $6.2B.
Among institutional investors, MiniMed Group Inc (MMED) drew the most net new fund positions in Q2 2026: 54 funds opened new positions, taking total fund holders up 40 (70%) quarter-over-quarter.
- Combined market cap: $67.7B across 13 stocks.
- Mid Cap: market cap between $2B and $10B.
- Largest constituent: Avantor (AVTR), $9.75B market cap.
- Most net new fund positions in Q2 2026: MiniMed Group Inc (MMED), +40 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.